Related Experiment Video

Updated: May 9, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Epirubicin-mediated expression of miR-302b is involved in osteosarcoma apoptosis and cell cycle regulation

Yi Zhang1, Hao Hu, Lu Song

  • 1Department of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.

Toxicology Letters
|July 13, 2013
PubMed

Insights

Epirubicin chemotherapy for osteosarcoma can alter microRNA (miRNA) expression. This study found miR-302b suppresses osteosarcoma growth by promoting apoptosis and cell cycle arrest, suggesting its therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Epirubicin is a key chemotherapy drug for osteosarcoma.
  • MicroRNA (miRNA) expression is implicated in osteosarcoma progression and response to chemotherapy.

Purpose of the Study:

  • To investigate miRNA expression changes in osteosarcoma cells following epirubicin treatment.
  • To determine if specific miRNAs can enhance the anti-osteosarcoma effects of epirubicin.

Main Methods:

  • Osteosarcoma cells were treated with epirubicin.
  • Microarray analysis was used to identify differentially expressed miRNAs.
  • Functional assays were performed to assess the role of miR-302b in cell proliferation, apoptosis, and cell cycle.

Main Results:

  • Microarray analysis revealed 40 differentially expressed miRNAs after epirubicin exposure, with 24 downregulated.
  • miR-302b, typically low in osteosarcoma, was induced by epirubicin.
  • miR-302b inhibited osteosarcoma cell proliferation, induced apoptosis (via caspase-3, Akt/pAkt, Bcl-2, Bim regulation), and caused cell cycle arrest (via cyclin D1, CDKs regulation).

Conclusions:

  • miR-302b exhibits tumor suppressor activity in osteosarcoma.
  • miR-302b holds potential as a therapeutic agent for osteosarcoma treatment.
Keywords:
EpirubicinMicrornaMirna-302bOsteosarcoma

More Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...